Thrivent Financial For Lutherans Insmed Inc Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023
BUY
$16.26 - $21.73 $2.65 Million - $3.55 Million
163,160 New
163,160 $2.78 Million
Q1 2021

May 17, 2021
SELL
$32.28 - $44.3 $1.17 Million - $1.6 Million
-36,230 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$26.0 - $34.5 $884 - $1,173
-34 Reduced 0.09%
36,230 $1.16 Million
Q1 2020

May 15, 2020
BUY
$13.63 - $33.98 $494,278 - $1.23 Million
36,264 New
36,264 $581,000

Others Institutions Holding INSM

# of Institutions
478
Shares Held
180M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email